Figure 2.
The forest plot evaluating the effect of angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) use on the overall incidence of contrast-induced nephropathy (CIN).
CI: confidence interval; RR: relative risk.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.